Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46efb3dcc7564d78c81e62a7b66b939f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
1990-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f50aa421c067df456657a9f06cd9dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598c1863a090831ebd5835f89bc616bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91a4671d942758c2ab728bcf6204aa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8042f9904a1d9eda59a749d64bf388b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69cead56ad3419346dc26c8ec9ad55c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50928279e9138c0f24797ab0d8f2639c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9bb8eaed6e8540618fd7e036fb9959a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ef9952fb8194157ffb11a9baa0f126a |
publicationDate |
1994-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
PL-165512-B1 |
titleOfInvention |
Method of producing extracellular exopolymer PL PL PL |
abstract |
An extracellular exopolymer endowed with immunomodulating properties is prepared by culturing the Bifidobacterium infantis longum strain deposited at the Institut Pasteur under No. I-885 in a suitable medium under anaerobic conditions. After the microorganisms are discarded from the culture medium, the exopolymer thus produced is isolated, concentrated and then precipitated by adding an organic solvent; finally the product resulting from the precipitation is lyophilized. The exopolymer thus obtained possesses an activity on cellular as well as on humoral immunity, and could thus be used as an immunomodulating agent in any potential therapeutic application. |
priorityDate |
1989-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |